A 2026 Informational Overview of the Herz P1 Smart Band's Subscription-Free Health Monitoring Features, Heart Rate and HRV ...
The terms of the agreement entail the acquisition of all of the outstanding shares of Masimo common stock by Danaher ...
On February 17, Danaher Corporation (NYSE:DHR) announced an agreement to acquire Masimo Corporation (NASDAQ:MASI) for nearly $9.9 billion.
Irvine medical device maker Masimo has entered an agreement to be acquired by Danaher, owner of Brea-based Beckman Coulter, in a $9.9 billion deal.
Dealbreaker on MSN
Danaher drops $10B to snatch Masimo in diagnostics push
The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...
Zacks Investment Research on MSN
Masimo's board backs Danaher's $9.9B cash acquisition proposal
Masimo MASI recently entered into a definitive agreement, pursuant to which it will be acquired by the global conglomerate, Danaher DHR, for a total consideration of $9.9 billion. Per the deal, ...
Diagnostics business unit News of the agreement sent Masimo’s Nasdaq-listed stock price up in value by more than 30 per cent, with the $180-per-share purchase price last achieved just under a year ago ...
Danaher is buying Masimo for $180 per share in cash. Here why MASI could push DHR stock higher in 2026. Danaher shares are ...
For those who like to run the numbers, Danaher claims it is paying “18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA ...
Danaher Corp. announced Tuesday it will acquire Masimo Corp. in a blockbuster $9.9 billion transaction, including debt, a move set to reshape the global diagnostics landscape. Kirkland & Ellis LLP is ...
Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results